Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Feb 21;82(6):1149–1157. doi: 10.1054/bjoc.1999.1055

Specifically regulated genes in malignant melanoma tissues identified by subtractive hybridization

R Hipfel 1, B Schittek 1, Y Bodingbauer 1, C Garbe 1
PMCID: PMC2363360  PMID: 10735498

Abstract

A polymerase chain reaction (PCR)-based subtractive hybridization technique was used to identify transformation-related genes in malignant melanoma. Melanoma biopsies were compared with tissues of benign melanocytic naevi and 549 gene fragments were screened using arrayed filters. Thirty-eight clones were confirmed to be differentially expressed representing 30 different genes (18 melanoma-specific and 12 naevus-specific genes). To further confirm differential gene expression, Northern blot analyses with six of the 30 genes as probes were performed. All six were differentially expressed in benign and malignant melanocytic lesions, specifically dbpB/YB-1, 67-kDa laminin receptor, CAGH-3, 71-kDa heat shock protein and two unknown genes. The expression levels of these genes were then analysed in 50 different tissues to determine their overall expression profile. In conclusion, the technique of PCR-based subtractive hybridization in combination with arrayed filters allows detection of differences in gene expression even in tissues from which high-quality RNA is hard to isolate. The genes identified in this study are of interest because of their potential role in the pathogenesis of malignant melanoma. © 2000 Cancer Research Campaign

Keywords: subtractive hybridization, array hybridization, differential gene expression, malignant melanoma, melanocyticnaevi

Full Text

The Full Text of this article is available as a PDF (138.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altschul S. F., Madden T. L., Schäffer A. A., Zhang J., Zhang Z., Miller W., Lipman D. J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997 Sep 1;25(17):3389–3402. doi: 10.1093/nar/25.17.3389. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bargou R. C., Jürchott K., Wagener C., Bergmann S., Metzner S., Bommert K., Mapara M. Y., Winzer K. J., Dietel M., Dörken B. Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression. Nat Med. 1997 Apr;3(4):447–450. doi: 10.1038/nm0497-447. [DOI] [PubMed] [Google Scholar]
  3. Clark W. H., Jr, From L., Bernardino E. A., Mihm M. C. The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res. 1969 Mar;29(3):705–727. [PubMed] [Google Scholar]
  4. Diatchenko L., Lau Y. F., Campbell A. P., Chenchik A., Moqadam F., Huang B., Lukyanov S., Lukyanov K., Gurskaya N., Sverdlov E. D. Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6025–6030. doi: 10.1073/pnas.93.12.6025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Feinberg A. P., Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. doi: 10.1016/0003-2697(83)90418-9. [DOI] [PubMed] [Google Scholar]
  6. Herlyn M., Malkowicz S. B. Regulatory pathways in tumor growth and invasion. Lab Invest. 1991 Sep;65(3):262–271. [PubMed] [Google Scholar]
  7. Herlyn M., Shih I. M. Interactions of melanocytes and melanoma cells with the microenvironment. Pigment Cell Res. 1994 Apr;7(2):81–88. doi: 10.1111/j.1600-0749.1994.tb00025.x. [DOI] [PubMed] [Google Scholar]
  8. Hipfel R., Garbe C., Schittek B. RNA isolation from human skin tissues for colorimetric differential display. J Biochem Biophys Methods. 1998 Nov 18;37(3):131–135. doi: 10.1016/s0165-022x(98)00023-2. [DOI] [PubMed] [Google Scholar]
  9. Ikeda H., Lethé B., Lehmann F., van Baren N., Baurain J. F., de Smet C., Chambost H., Vitale M., Moretta A., Boon T. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity. 1997 Feb;6(2):199–208. doi: 10.1016/s1074-7613(00)80426-4. [DOI] [PubMed] [Google Scholar]
  10. Kudo S., Mattei M. G., Fukuda M. Characterization of the gene for dbpA, a family member of the nucleic-acid-binding proteins containing a cold-shock domain. Eur J Biochem. 1995 Jul 1;231(1):72–82. doi: 10.1111/j.1432-1033.1995.tb20672.x. [DOI] [PubMed] [Google Scholar]
  11. Margolis R. L., Abraham M. R., Gatchell S. B., Li S. H., Kidwai A. S., Breschel T. S., Stine O. C., Callahan C., McInnis M. G., Ross C. A. cDNAs with long CAG trinucleotide repeats from human brain. Hum Genet. 1997 Jul;100(1):114–122. doi: 10.1007/s004390050476. [DOI] [PubMed] [Google Scholar]
  12. Mertens P. R., Harendza S., Pollock A. S., Lovett D. H. Glomerular mesangial cell-specific transactivation of matrix metalloproteinase 2 transcription is mediated by YB-1. J Biol Chem. 1997 Sep 5;272(36):22905–22912. doi: 10.1074/jbc.272.36.22905. [DOI] [PubMed] [Google Scholar]
  13. Néri C., Albanèse V., Lebre A. S., Holbert S., Saada C., Bougueleret L., Meier-Ewert S., Le Gall I., Millasseau P., Bui H. Survey of CAG/CTG repeats in human cDNAs representing new genes: candidates for inherited neurological disorders. Hum Mol Genet. 1996 Jul;5(7):1001–1009. doi: 10.1093/hmg/5.7.1001. [DOI] [PubMed] [Google Scholar]
  14. Real F. X., Rettig W. J., Chesa P. G., Melamed M. R., Old L. J., Mendelsohn J. Expression of epidermal growth factor receptor in human cultured cells and tissues: relationship to cell lineage and stage of differentiation. Cancer Res. 1986 Sep;46(9):4726–4731. [PubMed] [Google Scholar]
  15. Reed J. A., Loganzo F., Jr, Shea C. R., Walker G. J., Flores J. F., Glendening J. M., Bogdany J. K., Shiel M. J., Haluska F. G., Fountain J. W. Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res. 1995 Jul 1;55(13):2713–2718. [PubMed] [Google Scholar]
  16. Rodeck U. Growth factor independence and growth regulatory pathways in human melanoma development. Cancer Metastasis Rev. 1993 Sep;12(3-4):219–226. doi: 10.1007/BF00665954. [DOI] [PubMed] [Google Scholar]
  17. Sakura H., Maekawa T., Imamoto F., Yasuda K., Ishii S. Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology. Gene. 1988 Dec 20;73(2):499–507. doi: 10.1016/0378-1119(88)90514-8. [DOI] [PubMed] [Google Scholar]
  18. Shih I. M., Elder D. E., Hsu M. Y., Herlyn M. Regulation of Mel-CAM/MUC18 expression on melanocytes of different stages of tumor progression by normal keratinocytes. Am J Pathol. 1994 Oct;145(4):837–845. [PMC free article] [PubMed] [Google Scholar]
  19. Siebert P. D., Chenchik A., Kellogg D. E., Lukyanov K. A., Lukyanov S. A. An improved PCR method for walking in uncloned genomic DNA. Nucleic Acids Res. 1995 Mar 25;23(6):1087–1088. doi: 10.1093/nar/23.6.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Vacca A., Ribatti D., Roncali L., Lospalluti M., Serio G., Carrel S., Dammacco F. Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer. 1993 Jul 15;72(2):455–461. doi: 10.1002/1097-0142(19930715)72:2<455::aid-cncr2820720222>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  21. Wagner S. N., Wagner C., Schultewolter T., Goos M. Analysis of Pmel17/gp100 expression in primary human tissue specimens: implications for melanoma immuno- and gene-therapy. Cancer Immunol Immunother. 1997 Jun;44(4):239–247. doi: 10.1007/s002620050379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Wang Z., Brown D. D. A gene expression screen. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11505–11509. doi: 10.1073/pnas.88.24.11505. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Yehiely F., Oren M. The gene for the rat heat-shock cognate, hsc70, can suppress oncogene-mediated transformation. Cell Growth Differ. 1992 Nov;3(11):803–809. [PubMed] [Google Scholar]
  24. Zhang L., Zhou W., Velculescu V. E., Kern S. E., Hruban R. H., Hamilton S. R., Vogelstein B., Kinzler K. W. Gene expression profiles in normal and cancer cells. Science. 1997 May 23;276(5316):1268–1272. doi: 10.1126/science.276.5316.1268. [DOI] [PubMed] [Google Scholar]
  25. van der Bruggen P., Traversari C., Chomez P., Lurquin C., De Plaen E., Van den Eynde B., Knuth A., Boon T. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991 Dec 13;254(5038):1643–1647. doi: 10.1126/science.1840703. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES